Search results for "OBESITY"

showing 10 items of 1833 documents

Relationship between endocrine disruptors and obesity with a focus on bisphenol A: a narrative review

2021

International audience; Introduction: Scientific data suggest that early exposure to endocrine-disrupting chemicals (EDCs) affect -repro, -neuro, -metabolic systems, to which are added other notions such as mixtures, window and duration of exposure, trans-generational effects, and epigenetic mechanisms. Methods: In the present narrative review, we studied the relationship between exposure to EDCs with the appearance and development of obesity. Results: Exposure to EDCs like Bisphenol A during the early stages of development has been shown to lead to weight gain and obesity. EDCs can interfere with endocrine signaling, affect adipocytes differentiation and endocrine function and disrupt meta…

Medicine (General)obesityFuture studiesQH301-705.5bisphenol APharmaceutical Science030209 endocrinology & metabolismReviewBiologyBioinformaticsadipocyteGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineR5-920medicineEndocrine systemmetabolic disordersEpigeneticsBiology (General)030304 developmental biology0303 health sciencesfat tissuesLow doseGeneral Medicine[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciencesmedicine.diseaseObesity3. Good healthperoxisome proliferator-activated receptor-γNarrative review
researchProduct

Replication Data for: Examining the effects of an eHealth intervention from infant age 6 to 12 months on child eating behaviors and maternal feeding …

2019

This SPSS-dataset presents data from the Norwegian randomized controlled trial Early Food for Future Health. This project started in 2015, with the objective of developing an eHealth intervention providing guidance on protective feeding practices at child age 6-12 months aiming to promote healthy food habits from infancy. Previously, we have presented data obtained from the study`s web-based, self-administered questionnaires at baseline (child age 5 months) and after the end of the intervention (child age 12 months) on maternal feeding practices, child eating behaviour, food-intake and mealtime routines (n=533). Here we present follow-up data at child age 24 months, one year after cessation…

Medicine Health and Life Sciencespublic health eHealth early nutrition maternal feeding practices child eating behavior childhood overweight and obesity
researchProduct

Education modulates the association of the FTO rs9939609 polymorphism with body mass index and obesity risk in the Mediterranean population

2012

Objective To define whether the rs9939609 FTO (fat mass and obesity associated) single nucleotide polymorphism (SNP) is associated with anthropometric measurements and its modulation by educational level in a Mediterranean population. Methods We studied 3 independent adult samples: a random sample (n = 1580) from the general population (GP), obese hospital patients (OHP) (n = 203) and elderly subjects (n = 1027) with high cardiovascular risk (HCR). Weight and height were directly measured. Education and physical activity (PA) were measured using questionnaires. Results The rs9939609 presented heterogeneous associations with BMI. In the GP, the minor A-allele was significantly associated wit…

Mediterranean climateMaleEndocrinology Diabetes and MetabolismMedicine (miscellaneous)MediterraneanBody Mass IndexGene FrequencyPolymorphism (computer science)Risk FactorsSurveys and QuestionnairesOdds RatioPrevalenceGeneticsAged 80 and overeducation.field_of_studyNutrition and DieteticsAnthropometryMiddle AgedPhenotypeEducational StatusFemaleCardiology and Cardiovascular MedicineFTOAdultmedicine.medical_specialtyAdolescentPopulationAlpha-Ketoglutarate-Dependent Dioxygenase FTOSingle-nucleotide polymorphismBiologyMotor ActivityPolymorphism Single NucleotideRisk AssessmentArticleEducational levelYoung AdultInternal medicinemedicineSNPHumansGenetic Predisposition to DiseaseObesityeducationAgedChi-Square DistributionPhysical activitynutritional and metabolic diseasesProteinsAnthropometrymedicine.diseaseObesityEndocrinologyLogistic ModelsSpainMultivariate AnalysisLinear ModelsBody mass index
researchProduct

The Mediterranean diet and its individual components: Linking with obesity in Italy

2020

Abstract A prolonged positive energy balance may contribute to fat accumulation and obesity development. It was observed several years ago that population resident in southern Italy consumed a particular diet and was less obese and lived significantly longer, and it was referred as the Mediterranean diet. The Mediterranean diet is a dietary plan based on fruits, vegetables, olive oil, and low intake of saturated fatty acids. A large body of literature suggested that the Mediterranean diet is effective in preventing obesity. Both observational and intervention studies clearly demonstrated that a higher adherence to Mediterranean diet is associated with a reduced risk of being obese and that …

Mediterranean climateeducation.field_of_studyMediterranean dietbusiness.industryPopulationMediterranean diet obesity italymedicine.diseaseBody weightObesityPositive energyFat accumulationEnvironmental healthMedicineSettore MED/49 - Scienze Tecniche Dietetiche ApplicateeducationbusinessBeneficial effects
researchProduct

Emerging Increase in the prevalence and severity of nonalcoholic fatty liver disease: epidemiological study from general Mediterranean population

2016

Background and Aims: The worldwide spread of obesity and diabetes is leading to a drastic increase in nonalcoholic fatty liver disease (NAFLD) and its complications.We aimed to assess prevalence of NAFLD and of its severity among a general Mediterranean population. Methods:We considered 886 consecutive individuals included in the ABCD study (ISRCTN15840340). Hepatic ultrasound (US) was used to diagnose steatosis and FibroScan (M and XL probe) to measure liver stiffness and controlled attenuation parameter (CAP). Liver stiffness >6.9 KPa was considered suggestive of significant liver fibrosis (Petta S et al., Hepatology 2015), and CAP ≥ 310 dB was considered suggestive of moderate-severe …

Mediterranean climateeducation.field_of_studymedicine.medical_specialtyHepatologybusiness.industryPopulationGastroenterologymedicine.diseaseGastroenterologyobesity ABCD fatty liver disease hepatosteatosisInternal medicineNonalcoholic fatty liver diseaseEpidemiologyMedicineeducationbusiness
researchProduct

Dietary fiber intake and the Mediterranean population

2020

Abstract Dietary fiber encompasses carbohydrates not digested or absorbed in the small intestine, arriving intact to the colon. Its role in human health has been mentioned since the times of Hippocrates but only in the 1970s of the 20th century, and subsequently a myriad of epidemiological and clinical studies has shown that a diet with low content of dietary fiber is associated with several chronic diseases such as diabetes, cardiovascular diseases, certain neoplastic diseases, specially colon cancer, and also obesity. The Western dietary pattern, which is spreading in our current globalized world and in which many components are ultraprocessed, has very low fiber content. Conversely the M…

Mediterranean climatemedicine.medical_specialtyeducation.field_of_studyMediterranean dietPopulationBiologymedicine.diseaseMediterranean BasinObesityDiabetes mellitusEnvironmental healthEpidemiologymedicineDietary fibereducation
researchProduct

Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Trea…

2022

The obesity pandemic is accompanied by increased risk of developing metabolic syndrome (MetS) and related conditions: non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH), type 2 diabetes mellitus (T2DM) and cardiovascular (CV) disease (CVD). Lifestyle, as well as an imbalance of energy intake/expenditure, genetic predisposition, and epigenetics could lead to a dysmetabolic milieu, which is the cornerstone for the development of cardiometabolic complications. Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 RAs promote positive effects on most components of the “ cardiometabolic continuum” an…

Metabolic SyndromePharmacologyglucagon-like peptide-1 receptor agonists glucose-dependent insulinotropic polypeptide receptor agonists non-alcoholic fatty liver disease obesity prediabetes tirzepatide type 2 diabetes mellitusGlucagon-Like Peptide-1 ReceptorPrediabetic StateGlucoseDiabetes Mellitus Type 2Non-alcoholic Fatty Liver DiseaseGlucagon-Like Peptide 1HumansPharmacology (medical)ObesityPeptidesCardiology and Cardiovascular MedicineJournal of Cardiovascular Pharmacology and Therapeutics
researchProduct

The metabolic syndrome: Definition, diagnosis and management

2008

The metabolic syndrome (MetS) constitutes a major public health problem in the developed countries.(1) It is cited with different names, such as syndrome X, insulin resistance syndrome, Reaven's syndrome or CHAOS (Australia). MetS increases the cardiovascular risk, but with specific lifestyle changes and individualized drug treatment the development of serious vascular complications can be avoided. In the last years, MetS has become a prevalent clinical condition. Therefore, it is necessary to create a complete document on the diagnosis and clinical management of MetS to avoid the confusion that derives from the vast amount of scientific papers, different revisions and definitions of the sy…

Metabolic SyndromeSettore MED/09 - Medicina InternaTHE METABOLIC SYNDROME: DEFINITION DIAGNOSIS AND MANAGEMENTRisk AssessmentEatingTreatment OutcomeCardiovascular DiseasesRisk FactorsTerminology as TopicHumansHypoglycemic AgentsAnti-Obesity AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsExerciseLife StyleAntihypertensive Agents
researchProduct

Magnesium in Type 2 Diabetes Mellitus, Obesity, and Metabolic Syndrome

2021

Metabolic syndrome is a constellation of risk factors, including obesity, hypertension, insulin resistance, and altered lipid profile, which, if left untreated, will often progress to type 2 diabetes, which frequently complicates the syndrome [...]

Metabolic Syndromen/aNutrition and DieteticsDiabetes Mellitus Type 2Nutrition. Foods and food supplyHumansTX341-641MagnesiumObesityInsulin ResistanceFood ScienceNutrients
researchProduct

ITCH E3 ubiquitin ligase downregulation compromises hepatic degradation of branched-chain amino acids

2022

Objective: Metabolic syndrome, obesity, and steatosis are characterized by a range of dysregulations including defects in ubiquitin ligase tagging proteins for degradation. The identification of novel hepatic genes associated with fatty liver disease and metabolic dysregulation may be relevant to unravelling new mechanisms involved in liver disease progression Methods: Through integrative analysis of liver transcriptomic and metabolomic obtained from obese subjects with steatosis, we identified itchy E ubiquitin protein ligase (ITCH) as a gene downregulated in human hepatic tissue in relation to steatosis grade. Wild-type or ITCH knockout mouse models of non-alcoholic fatty liver disease (N…

Mice KnockoutBCAAm Metabolomic NAFLD TranscriptomicsUbiquitin-Protein Ligases[SDV]Life Sciences [q-bio]Liver NeoplasmsDown-RegulationBCAA; Metabolomics; NAFLD; Transcriptomics.Settore MED/09Cell BiologyMiceNon-alcoholic Fatty Liver DiseaseNAFLDotorhinolaryngologic diseasesAnimalsHumansMetabolomicsFemaleObesityBCAAskin and connective tissue diseasesTranscriptomicsMolecular BiologyAmino Acids Branched-Chain
researchProduct